A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Finland, as Part of Local Clinical Practice
Clinical trial NCT05443191 · COMPLETED
Trial details
- NCT number
- NCT05443191
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-10-20
- Primary completion
- 2023-04-27
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.